Türk Karaciğer Araştırmaları Derneği


Michael MANNS, MD

President and Board Member for Research and Education of Hannover Medical School
Gastroenterology and Hepatology
Germany

Professor Michael P. Manns is the President and Board Member for Research and Education of Hannover Medical School (MHH), Hannover, Germany, since January 1, 2019. He graduated in medicine from the University of Vienna in Austria and the University of Mainz in Germany before completing postgraduate training at the Freie Universität Berlin, Germany, and the University of Mainz, where he became Professor of Medicine in 1986. Subsequently, Professor Manns was a Research Associate at the Scripps Clinic and Research Foundation, La Jolla, California, USA from 1987 to 1988. He was the Director of the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School from 1991 to 2020 and from 2015 – 2018 he was Clinical Director of the Helmholtz Center for Infection Research (HZI), Braunschweig, Germany, and founding director of the Center for Individualized Infection Medicine (CiiM), Hannover. 2015 – 2020 he was member of the Scientific Panel for Health (SPH) of the European Commission in Brussels. Professor Manns is founder and chairman of HepNet, a national network of competence on viral hepatitis and the German Liver Foundation. He was President of the German Society of Gastroenterology (DGVS) in 2006, the German Association for the Study of the Liver (GASL) in 2013, the German Society of Internal Medicine (DGIM) in 2014 and United European Gastroenterology (UEG) from 2015 –2017. Prof. Manns was awarded for his lifetime achievement by the UEG in 2022. Professor Manns has received numerous awards including the International Hans Popper Award in 1995 and the European Association for the Study of the Liver (EASL) Recognition Award in 2007. Professor Manns has a long-term research interest in liver diseases with a main focus on viral hepatitis, autoimmune liver diseases, hepatocellular carcinoma, liver transplantation, regenerative medicine, and cell therapy. He has published more than 1000 articles in international peer-reviewed journals such as The New England Journal of Medicine, The Lancet, Nature, Nature Medicine, Cell, astroenterology, and Hepatology among others. His Hirsch index is >123 (Web-of-Science, March, 2022). According to Thomson Reuters/Clarivate Analytics he ranks among the top 1% of most cited researchers since 2014.